• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Rheumatology

Latest News

Although the study did not stratify risk across patient subgroups, the authors suggest that integrated genetic, serologic, and clinical risk stratification tools could enhance risk prediction. | Image Credit: MicroOne - stock.adobe.com
Genetic Study Establishes Causal Link Between RA and Interstitial Lung Disease Risk

November 21st 2025

A combined assessment of genetic, serologic, and clinical factors may enhance early recognition of patients with RA who are most at risk for ILD.

Consistent associations across 3 independent groups strengthen the biological link between IPF-related biomarkers and RA-ILD risk. | Image credit: JR-50 - stock.adobe.com
Shared Molecular Pathways Link IPF and RA-Associated Lung Disease

October 31st 2025

Given the apparent connection between weight and RA, the investigators wanted to see if the new high-profile GLP-1RAs might provide a particular benefit to patients with RA who were also overweight. | Image credit: mingnimit - stock.adobe.com
GLP-1 Receptor Agonists May Improve Rheumatoid Arthritis Symptoms

October 24th 2025

Metabolomic profiling of 244 patients with rheumatoid arthritis and 69 controls identified 111 differential metabolites, including 33 upregulated and 78 downregulated compounds. | Image credit: Oporty786 - stock.adobe.com
Tryptophan Metabolism Linked to csDMARD Response in Rheumatoid Arthritis

October 17th 2025

RA remains the most prevalent autoimmune chronic inflammatory joint disease, with DMARD adherence profoundly influencing long-term outcomes. | Image Credit: MicroOne - stock.adobe.com
Wide Gaps in DMARD Adherence Reporting Complicate Rheumatoid Arthritis Care

October 15th 2025

More News

Site Logo

The Future of Outcomes Measurement in Rheumatology

Robert M. Kaplan, PhD
December 1st 2007

Read More

ACR Supports Continued Use of Telemedicine and Reimbursement Parity After COVID-19 Crisis

ACR Supports Continued Use of Telemedicine and Reimbursement Parity After COVID-19 Crisis

Laura Joszt, MA
December 1st 1997

The widespread adoption of telemedicine during the coronavirus disease 2019 (COVID-19) pandemic, as well as reimbursement parity that was enacted by CMS, should be continued once the public health emergency passes, according to a new position statement by the American College of Rheumatology (ACR).

Read More

<1
...
7891011
© 2025 MJH Life Sciences
AJMC®
All rights reserved.